Document ID: chunk:federal_register_of_legislation:F2024N01149:schedule:1:p4
Version: federal_register_of_legislation:F2024N01149
Segment Type: schedule
Provision Reference: sch 1 (pt 4/6)
Character Range: 16570–21252

Pharmaceutical Benefits Scheme Prescribing requirements, pharmaceutical dose, form and strength; and
                (b)                 the pharmaceutical benefit's:
                    (i)                  date and time of prescribing; and
                    (ii)                dose; and
                    (iii)              route of administration; and
                    (iv)              frequency of administration; and
                    (v)                 site of administration (if appropriate); and
                    (vi)              indication for prescribing; and
                    (vii)            PBS Authority Approval Number/s if required; and
                (c)                 the indication for administration of the pharmaceutical benefit; and
                (d)                 maximum individual dose or range; and
                (e)                 minimum interval between administrations; and
                (f)                  maximum dose in 24 hours; and
                (g)                 the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and
                (h)                 the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and
                (i)                  specified duration or indication that medicine is to be supplied for duration of chart; and
                (j)                  brand substitution indicator; and
                (k)                 Authority Prescription Number; and
                (l)                  Closing the Gap (CTG); and
                (m)              PBS/RPBS; and
                (n)                 Streamlined Authority; and
                (o)                 additional instructions (if any) to be added by the medical practitioner, expressed as 'Additional Instructions'.
            10.2            Information requirements for a pharmaceutical benefit, other than insulin, that is required to be administered PRN (as required) must also include a record of each administration of the benefit including:
                (a)                 pharmaceutical benefit; and
                (b)                 form; and
                (c)                 strength; and
                (d)                 dose administered; and
                (e)                 route; and
                (f)                  reason for administration of the pharmaceutical benefit; and
                (g)                 date and time; and
                (h)                 credentials of Nurse administering the pharmaceutical benefit; and
                (i)                  outcome or effect of medicine and time observation was made; and
                (j)                  credentials of Nurse recording the observation.

      11.  Variable dose pharmaceutical benefits (non-insulin)

            11.1            The information requirements for a pharmaceutical benefit, other than insulin, that is required to be administered at a variable dose must include the following:
                (a)                 particulars sufficient to identify the pharmaceutical benefit, in line with Pharmaceutical Benefits Scheme Prescribing requirements, pharmaceutical dose, form and strength; and
                (b)                 the pharmaceutical benefit's:
                    (i)                  date and time of prescribing; and
                    (ii)                dose; and
                    (iii)              route of administration; and
                    (iv)              frequency of administration; and
                    (v)                 site of administration (if appropriate); and
                    (vi)              Indication for prescribing; and
                    (vii)            PBS Authority Approval Number/s if required; and
                (c)                 the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and
                (d)                 the start time for administration (if necessary); and
                (e)                 the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and
                (f)                  specified duration or indication that medicine is to be supplied for duration of chart; and
                (g)                 brand substitution indicator; and
                (h)                 Authority Prescription Number; and
                (i)                  Closing the Gap (CTG); and
                (j)                  PBS/RPBS; and
                (k)                 Streamlined Authority;